Sponsor:
Pfizer
Code:
NCT06524414
Conditions
Pneumococcal Disease
Eligibility Criteria
Sex: All
Age: 42 - 70+
Healthy Volunteers: Accepted
Interventions
PG4
20-valent pneumococcal conjugate vaccine (20vPnC)
15-valent pneumococcal conjugate vaccine (PCV15)
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by Pfizer on 2025-04-02.